Literature DB >> 21361347

Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors.

Urszula Golebiewska1, Jennifer M Johnston, Lakshmi Devi, Marta Filizola, Suzanne Scarlata.   

Abstract

Prolonged morphine treatment induces extensive desensitization of the μ-opioid receptor (μOR) which is the G-protein-coupled receptor that primarily mediates the cellular response to morphine. To date, the molecular mechanism underlying this process is unknown. Here, we have used live cell fluorescence imaging to investigate whether prolonged morphine treatment affects the physical environment of μOR, or its coupling with G-proteins, in two neuronal cell lines. We find that chronic morphine treatment does not change the amount of enhanced yellow fluorescence protein (eYFP)-tagged μOR on the plasma membrane, and only slightly decreases its association with G-protein subunits. Additionally, morphine treatment does not have a detectable effect on the diffusion coefficient of eYFP-μOR. However, in the presence of another family member, the δ-opioid receptor (δOR), prolonged morphine exposure results in a significant increase in the diffusion rate of μOR. Number and brightness measurements suggest that μOR exists primarily as a dimer that will oligomerize with δOR into tetramers, and morphine promotes the dissociation of these tetramers. To provide a plausible structural context to these data, we used homology modeling techniques to generate putative configurations of μOROR tetramers. Overall, our studies provide a possible rationale for morphine sensitivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361347      PMCID: PMC3071705          DOI: 10.1021/bi101701x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

Review 1.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Visualization of a functional Galpha q-green fluorescent protein fusion in living cells. Association with the plasma membrane is disrupted by mutational activation and by elimination of palmitoylation sites, but not be activation mediated by receptors or AlF4-.

Authors:  T E Hughes; H Zhang; D E Logothetis; C H Berlot
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

Review 3.  Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking.

Authors:  L A Devi
Journal:  Trends Pharmacol Sci       Date:  2001-10       Impact factor: 14.819

Review 4.  G-protein-coupled receptors at a glance.

Authors:  Wesley K Kroeze; Douglas J Sheffler; Bryan L Roth
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

5.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Authors:  Ivone Gomes; Achla Gupta; Julija Filipovska; Hazel H Szeto; John E Pintar; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

6.  Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes.

Authors:  Z Xia; Y Liu
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

7.  Live cell imaging of Gs and the beta2-adrenergic receptor demonstrates that both alphas and beta1gamma7 internalize upon stimulation and exhibit similar trafficking patterns that differ from that of the beta2-adrenergic receptor.

Authors:  Thomas R Hynes; Stacy M Mervine; Evan A Yost; Jonathan L Sabo; Catherine H Berlot
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

8.  Dynamics of beta2-adrenergic receptor-ligand complexes on living cells.

Authors:  Oliver Hegener; Lars Prenner; Frank Runkel; Stephan Leonhardt Baader; Joachim Kappler; Hanns Häberlein
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

9.  The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant.

Authors:  Peng Huang; Irache Visiers; Harel Weinstein; Lee-Yuan Liu-Chen
Journal:  Biochemistry       Date:  2002-10-08       Impact factor: 3.162

10.  Galphaq binds two effectors separately in cells: evidence for predetermined signaling pathways.

Authors:  Urszula Golebiewska; Suzanne Scarlata
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

View more
  22 in total

1.  The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.

Authors:  Shou-Pu Yi; Qing-Hong Kong; Yu-Lei Li; Chen-Ling Pan; Jie Yu; Ben-Qiang Cui; Ying-Fei Wang; Guan-Lin Wang; Pei-Lan Zhou; Li-Li Wang; Ze-Hui Gong; Rui-Bin Su; Yue-Hai Shen; Gang Yu; Kwen-Jen Chang
Journal:  Acta Pharmacol Sin       Date:  2017-05-15       Impact factor: 6.150

Review 2.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

3.  A loss in cellular protein partners promotes α-synuclein aggregation in cells resulting from oxidative stress.

Authors:  Yuanjian Guo; Suzanne Scarlata
Journal:  Biochemistry       Date:  2013-05-21       Impact factor: 3.162

4.  Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.

Authors:  Kévin Carayon; Lionel Moulédous; Anne Combedazou; Serge Mazères; Evert Haanappel; Laurence Salomé; Catherine Mollereau
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

5.  Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor.

Authors:  Dar'ya S Redka; Takefumi Morizumi; Gwendolynne Elmslie; Pranavan Paranthaman; Rabindra V Shivnaraine; John Ellis; Oliver P Ernst; James W Wells
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

Review 6.  Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 7.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

Review 8.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 9.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Phospholipase Cβ-TRAX Association Is Required for PC12 Cell Differentiation.

Authors:  Osama Garwain; Suzanne Scarlata
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.